Risk factors for viral reactivation following bone marrow transplantation
- 1 January 1992
- journal article
- research article
- Published by Springer Nature in Annals of Hematology
- Vol. 64 (S1) , A148-A151
- https://doi.org/10.1007/bf01715370
Abstract
The identification of risk factors for viral reactivation following transplantation is essential in order that antiviral prophylactic regimes may be allocated rationally. In the pretransplant period qualitative serological assessment of recipient and donor is informative with regard to the risk of post-transplant reactivation and disease. In addition, the quantitative level of herpes simplex virus (HSV) IgG in the pretransplant recipient is predictive of post-transplant HSV excretion, although this relationship does not exist for other viruses of the herpes group. We discuss the value of surveillance cultures for cytomegalovirus in the post-transplant period in predicting the development of CMV disease, and how this may allow effective intervention to prevent what is a major cause of morbidity and mortality in the transplant population.Keywords
This publication has 21 references indexed in Scilit:
- A Randomized, Controlled Trial of Prophylactic Ganciclovir for Cytomegalovirus Pulmonary Infection in Recipients of Allogeneic Bone Marrow TransplantsNew England Journal of Medicine, 1991
- Cytomegalovirus excretion after bone marrow transplantation cannot be predicted from the pre‐transplant level of IgG antibodiesJournal of Medical Virology, 1991
- SYMPTOMATIC CYTOMEGALOVIRUS INFECTION IN SEROPOSITIVE KIDNEY RECIPIENTS: REINFECTION WITH DONOR VIRUS RATHER THAN REACTIVATION OF RECIPIENT VIRUSThe Lancet, 1988
- Acyclovir for Prevention of Cytomegalovirus Infection and Disease after Allogeneic Marrow TransplantationNew England Journal of Medicine, 1988
- IMMUNE DONORS CAN PROTECT MARROW-TRANSPLANT RECIPIENTS FROM SEVERE CYTOMEGALOVIRUS INFECTIONSThe Lancet, 1987
- Radioimmunoassay for the detection of IgG antibodies to herpes simplex virus and its use as a prognostic indicator of HSV excretion in transplant recipientsJournal of Medical Virology, 1987
- Risk Factors for Cytomegalovirus Infection after Human Marrow TransplantationThe Journal of Infectious Diseases, 1986
- TRANSFER OF A FUNCTIONING HUMORAL IMMUNE SYSTEM IN TRANSPLANTATION OF T-LYMPHOCYTE-DEPLETED BONE MARROWThe Lancet, 1986
- TRANSMISSION OF CYTOMEGALOVIRUS BY RENAL ALLOGRAFT DEMONSTRATED BY RESTRICTION ENZYME ANALYSISThe Lancet, 1983
- Identification of Patients with Increased Risk of Infection with Herpes Simplex Virus after Renal TransplantationThe Journal of Infectious Diseases, 1979